Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apert syndrome
|
24 | 0.617 | 0.600 | 10 | 121520163 | missense variant | G/A;C | snv | 5.6E-05; 4.0E-06 | 0.800 | 0.960 | 25 | 1995 | 2018 | |||||
Pfeiffer Syndrome
|
36 | 0.617 | 0.600 | 10 | 121520163 | missense variant | G/A;C | snv | 5.6E-05; 4.0E-06 | 0.710 | 1.000 | 9 | 1995 | 2015 | |||||
Craniosynostosis
|
90 | 0.617 | 0.600 | 10 | 121520163 | missense variant | G/A;C | snv | 5.6E-05; 4.0E-06 | 0.050 | 1.000 | 5 | 2004 | 2017 | |||||
endometrial adenoacanthoma
|
12 | 0.617 | 0.600 | 10 | 121520163 | missense variant | G/A;C | snv | 5.6E-05; 4.0E-06 | 0.700 | 1.000 | 3 | 2008 | 2012 | |||||
Syndactyly
|
26 | 0.617 | 0.600 | 10 | 121520163 | missense variant | G/A;C | snv | 5.6E-05; 4.0E-06 | 0.030 | 1.000 | 3 | 1998 | 2004 | |||||
Abnormality of the skull
|
11 | 0.617 | 0.600 | 10 | 121520163 | missense variant | G/A;C | snv | 5.6E-05; 4.0E-06 | 0.020 | 1.000 | 2 | 2014 | 2017 | |||||
Cleft Palate
|
158 | 0.617 | 0.600 | 10 | 121520163 | missense variant | G/A;C | snv | 5.6E-05; 4.0E-06 | 0.020 | 1.000 | 2 | 2002 | 2013 | |||||
Cleft palate, isolated
|
70 | 0.617 | 0.600 | 10 | 121520163 | missense variant | G/A;C | snv | 5.6E-05; 4.0E-06 | 0.020 | 1.000 | 2 | 2002 | 2013 | |||||
Craniofacial Dysostosis
|
29 | 0.617 | 0.600 | 10 | 121520163 | missense variant | G/A;C | snv | 5.6E-05; 4.0E-06 | 0.020 | 1.000 | 2 | 1997 | 2014 | |||||
Craniofacial dysostosis type 1
|
52 | 0.617 | 0.600 | 10 | 121520163 | missense variant | G/A;C | snv | 5.6E-05; 4.0E-06 | 0.720 | 1.000 | 2 | 1997 | 2014 | |||||
Endometrial Neoplasms
|
32 | 0.617 | 0.600 | 10 | 121520163 | missense variant | G/A;C | snv | 5.6E-05; 4.0E-06 | 0.700 | 1.000 | 2 | 2011 | 2014 | |||||
Uranostaphyloschisis
|
75 | 0.617 | 0.600 | 10 | 121520163 | missense variant | G/A;C | snv | 5.6E-05; 4.0E-06 | 0.020 | 1.000 | 2 | 2002 | 2013 | |||||
Acrocephalosyndactylia
|
1 | 0.617 | 0.600 | 10 | 121520163 | missense variant | G/A;C | snv | 5.6E-05; 4.0E-06 | 0.700 | 1.000 | 1 | 2000 | 2000 | |||||
Adenocarcinoma
|
168 | 0.617 | 0.600 | 10 | 121520163 | missense variant | G/A;C | snv | 5.6E-05; 4.0E-06 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Amblyopia
|
29 | 0.617 | 0.600 | 10 | 121520163 | missense variant | G/A;C | snv | 5.6E-05; 4.0E-06 | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||
Astigmatism
|
45 | 0.617 | 0.600 | 10 | 121520163 | missense variant | G/A;C | snv | 5.6E-05; 4.0E-06 | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||
Blepharoptosis
|
57 | 0.617 | 0.600 | 10 | 121520163 | missense variant | G/A;C | snv | 5.6E-05; 4.0E-06 | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||
Childhood Osteosarcoma
|
151 | 0.617 | 0.600 | 10 | 121520163 | missense variant | G/A;C | snv | 5.6E-05; 4.0E-06 | 0.010 | 1.000 | 1 | 2004 | 2004 | |||||
Endometrial Carcinoma
|
326 | 0.617 | 0.600 | 10 | 121520163 | missense variant | G/A;C | snv | 5.6E-05; 4.0E-06 | 0.710 | 1.000 | 1 | 2011 | 2011 | |||||
Gastric Adenocarcinoma
|
235 | 0.617 | 0.600 | 10 | 121520163 | missense variant | G/A;C | snv | 5.6E-05; 4.0E-06 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Global developmental delay
|
553 | 0.617 | 0.600 | 10 | 121520163 | missense variant | G/A;C | snv | 5.6E-05; 4.0E-06 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Malignant Uterine Corpus Neoplasm
|
152 | 0.617 | 0.600 | 10 | 121520163 | missense variant | G/A;C | snv | 5.6E-05; 4.0E-06 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Muenke Syndrome
|
11 | 0.617 | 0.600 | 10 | 121520163 | missense variant | G/A;C | snv | 5.6E-05; 4.0E-06 | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||
Myopia
|
167 | 0.617 | 0.600 | 10 | 121520163 | missense variant | G/A;C | snv | 5.6E-05; 4.0E-06 | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||
Neoplasms
|
1644 | 0.617 | 0.600 | 10 | 121520163 | missense variant | G/A;C | snv | 5.6E-05; 4.0E-06 | 0.010 | 1.000 | 1 | 2007 | 2007 |